Literature DB >> 2840199

A monoclonal antibody to the carbohydrate chain on human hepatocellular carcinoma-associated antigen which suppressed tumor growth in nude mice.

Y Fukuda1, K Imai, K Miura, M Matsui, T Nakanishi, H Nakazato, J Masukawa, T Higashide, Y Hinoda, T Noguchi.   

Abstract

There have been few reports stating that monoclonal antibody alone inhibits human solid tumor growth in vivo. The present study demonstrated that monoclonal antibody S1 (IgG2a), which recognized the antigenic determinant of the carbohydrate moiety, showed antibody-dependent cell (or macrophage)-mediated cytotoxicity (ADCC or ADMC) in conjunction with murine splenocytes of both BALB/c and athymic mice. In vivo experiments demonstrated that the antibody S1 clearly prolonged the survival of athymic mice which had been inoculated with a human liver carcinoma cell line. In addition, the antibody S1 significantly suppressed the human hepatoma line transplanted s.c. into nude mice. 125I-Labeled monoclonal antibody S1 revealed that the antibody accumulated significantly in the tumor mass. Many mononuclear cells were observed surrounding tumor cells when the antibody was given. This model system might be useful for analyzing the ADCC (or ADMC) mechanism in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840199     DOI: 10.1007/BF00205754

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  25 in total

1.  Antibody-dependent cell-mediated cytotoxicity using monoclonal antibodies reacting with CEA.

Authors:  K Imai; T Sasanami; H Fujita; Y Moriya; M Tsujisaki; M Kawaharada; S Ferrone; A Yachi
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

2.  Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera.

Authors:  K Imai; S Ferrone
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

3.  Monoclonal anti-MM46 antibody:ricin A chain conjugate: in vitro and in vivo antitumor activity.

Authors:  M Seto; N Umemoto; M Saito; Y Masuho; T Hara; T Takahashi
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

4.  Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells.

Authors:  Z Steplewski; M D Lubeck; H Koprowski
Journal:  Science       Date:  1983-08-26       Impact factor: 47.728

5.  Circulating blood group-related antigen(s) in cancer patients detected by the monoclonal antibodies produced against hepatocellular carcinoma cell line.

Authors:  K Imai; T Sasanami; T Nakanishi; T Noguchi; A Yachi
Journal:  Tumour Biol       Date:  1985

6.  IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.

Authors:  D Herlyn; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

7.  All classes of murine IgG antibody mediate macrophage phagocytosis and lysis of erythrocytes.

Authors:  P Ralph; I Nakoinz; B Diamond; D Yelton
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

8.  Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.

Authors:  B S Wilson; K Imai; P G Natali; S Ferrone
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

9.  Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells.

Authors:  D Herlyn; J Powe; A H Ross; M Herlyn; H Koprowski
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

10.  Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies.

Authors:  T J Kipps; P Parham; J Punt; L A Herzenberg
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.